| 000 | 01647 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513234204.0 | ||
| 264 | 0 | _c20010628 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 024 | 7 |
_a10.1038/sj.bmt.1702792 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSkoda-Smith, S | |
| 245 | 0 | 0 |
_aTreatment of post-transplant lymphoproliferative disease with induction chemotherapy followed by haploidentical peripheral blood stem cell transplantation and Rituximab. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cFeb 2001 |
||
| 300 |
_a329-32 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aHaplotypes _ximmunology |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xetiology |
| 650 | 0 | 4 |
_aLymphoproliferative Disorders _xetiology |
| 650 | 0 | 4 |
_aMajor Histocompatibility Complex _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aSevere Combined Immunodeficiency _xcomplications |
| 700 | 1 | _aDouglas, V K | |
| 700 | 1 | _aMehta, P | |
| 700 | 1 | _aGraham-Pole, J | |
| 700 | 1 | _aWingard, J R | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 27 _gno. 3 _gp. 329-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1702792 _zAvailable from publisher's website |
| 999 |
_c11212970 _d11212970 |
||